亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer

甲状腺间变性癌 免疫疗法 医学 癌症免疫疗法 甲状腺癌 癌症研究 癌症 肿瘤科 免疫学 内科学
作者
Lisha Bao,Ying Li,Xiaoping Hu,Yingying Gong,Jinming Chen,Ping Cheong Huang,Zhuo Tan,Minghua Ge,Zongfu Pan
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:133: 112102-112102 被引量:20
标识
DOI:10.1016/j.intimp.2024.112102
摘要

Anaplastic thyroid carcinoma (ATC) is the most aggressive subtype of thyroid cancer with few effective therapies. Though immunotherapies such as targeting PD-1/PD-L1 axis have benefited patients with solid tumor, the druggable immune checkpoints are quite limited in ATC. In our study, we focused on the anti-tumor potential of sialic acid-binding Ig-like lectins (Siglecs) in ATC. Through screening by integrating microarray datasets including 216 thyroid-cancer tissues and single-cell RNA-sequencing, SIGLEC family members CD33, SIGLEC1, SIGLEC10 and SIGLEC15 were significantly overexpressed in ATC, among which SIGLEC15 increased highest and mainly expressed on cancer cells. SIGLEC15high ATC cells are characterized by high expression of serine protease PRSS23 and cancer stem cell marker CD44. Compared with SIGLEC15low cancer cells, SIGLEC15high ATC cells exhibited higher interaction frequency with tumor microenvironment cells. Further study showed that SIGLEC15high cancer cells mainly interacted with T cells by immunosuppressive signals such as MIF-TNFRSF14 and CXCL12-CXCR4. Notably, treatment of anti-SIGLEC15 antibody profoundly increased the cytotoxic ability of CD8+ T cells in a co-culture model and zebrafish-derived ATC xenografts. Consistently, administration of anti-SIGLEC15 antibody significantly inhibited tumor growth and prolonged mouse survival in an immunocompetent model of murine ATC, which was associated with increase of M1/M2, natural killer (NK) cells and CD8+ T cells, and decrease of myeloid-derived suppressor cells (MDSCs). SIGLEC15 inhibited T cell activation by reducing NFAT1, NFAT2, and NF-κB signals. Blocking SIGLEC15 increased the secretion of IFN-γ and IL-2 in vitro and in vivo. In conclusion, our finding demonstrates that SIGLEC15 is an emerging and promising target for immunotherapy in ATC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
佳佳发布了新的文献求助10
5秒前
乐乐的应助被佳佳采纳,获得10
11秒前
qiao完成签到,获得积分10
17秒前
yysmile完成签到 ,获得积分10
19秒前
城北徐公完成签到 ,获得积分10
30秒前
46秒前
369ninja的应助被科研通管家采纳,获得10
46秒前
46秒前
46秒前
ding的应助被科研通管家采纳,获得10
46秒前
46秒前
顾矜的应助被何何何采纳,获得10
1分钟前
linghanlan完成签到,获得积分10
1分钟前
土豆完成签到,获得积分10
1分钟前
苹果梦蕊完成签到 ,获得积分10
1分钟前
苗条雨完成签到,获得积分10
1分钟前
1分钟前
wang1231发布了新的文献求助10
1分钟前
斯文败类的应助被www采纳,获得10
2分钟前
2分钟前
辛勤的冰珍完成签到,获得积分10
2分钟前
何何何发布了新的文献求助10
2分钟前
可爱的函函的应助被于贝贝采纳,获得50
2分钟前
FashionBoy的应助被Gp1983采纳,获得30
2分钟前
感动的仇天完成签到,获得积分10
2分钟前
田様的应助被不辣的皮特采纳,获得50
2分钟前
dou完成签到 ,获得积分10
2分钟前
2分钟前
852的应助被何何何采纳,获得10
2分钟前
2分钟前
风吹麦浪的应助被听话的老太采纳,获得20
2分钟前
于贝贝完成签到,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
n01W97的应助被科研通管家采纳,获得10
2分钟前
于贝贝发布了新的文献求助50
2分钟前
传奇3的应助被美满冷安采纳,获得10
2分钟前
昏睡的映阳完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190113
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21852139
捐赠科研通 7788294
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559990
邀请新用户注册赠送积分活动 2482862